In partnership with the State University of New York at Buffalo School of Medicine and Biomedical Sciences, Windsong is pleased to provide the following continuing education conference.
This conference originally took place on September 12, 2020.
This conference was released on December 4, 2020 and will be valid until December 4, 2023.
This seminar is appropriate for all Physicians, PCP’s, Internists, OB/GYN physicians, PA’s and NP’s
Once we receive your registration, a link to the post test and evaluation will be sent along with the You Tube link to the conference. Please note that a score of 70% is required to obtain the 4.0 AMA PRA Category 1 Credit(s)TM). Certificates of credit will be provided by Windsong once you have completed your posttest.
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University at Buffalo Jacobs School of Medicine and Biomedical Sciences and Windsong Radiology Group.
The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.
CERTIFICATION
The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this internet enduring material activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Activity Director – Dr. Thomas Summers
- Planning committee member – Gina Fedele
To register at no cost, please click here.
The lectures for this online conference will include the following:
Minimally Invasive Treatments Changing and Saving Lives – Safet Lekperic, MD
- Learning Objectives:
- Educate attendees on minimally invasive treatments for conditions such as lower extremity including kyphoplasty, prostate artery embolization and venous insufficiency.
- Understand the cost and time efficiencies of minimally invasive treatments and benefits of keeping patient out of the hospital.
Future of PET – Eric Snitzer, MD and Patrick Lahr, MD
- Learning Objectives:
- To discuss the overall usage and impact of PET/CT over the past decade, including discussion of technical advances of PET/CT scanners, with a focus on digital technology.
- To for clinical use over the past few years, and to more briefly discuss additional radiotracers expected to become available in the near future. discuss the indications, pharmacology, efficacy and imaging of the various newer PET radiotracers that have become available.
Clinical Decision Support Update – David Wolf, MD
- Learning Objectives:
- Refresh primary care providers and other specialty providers on the ensuing mandate to utilize clinical decision support for all Medicare patients beginning Jan 1, 2022.
- Educate referring providers on elements required in clinical order to rendering imaging provider and potential for incentive under the quality payment program.
- Demonstrate use of clinical decision support tools for select clinical indications.
Breast Cancer Detection in Men – Anna Chen, DO
- Learning Objectives:
- Learn about differences between breast cancer in men vs. women.
- Become familiar with current guidelines in diagnosis and treatment for men.
- Discuss genetic testing and possible implications for future targeted screening for at risk men.
Using AI for Breast and Genetic Risk Assessment – Laura Fisher, MS, CGC
- Learning Objectives:
- Attendees will learn how artificial intelligence can improve efficiency in determining a patient’s lifetime breast cancer risk assessment.
- Attendees will learn how artificial intelligence can identify more candidates for genetic counseling and testing.
- Attendees will learn how using artificial intelligence will increase compliance with USPSTF recommendations for mammography screening, genetic counseling and testing and more.
Liquid Plasma Biopsy – Herbert Duvivier, MD
- Learning Objectives:
- Attendees will learn what a liquid biopsy is
- Attendees will discover how liquid biopsy is utilized in the treatment of lung cancer.
All of the conference speakers have no disclosures to report.
